Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New drug introduction 1973-1974.

P de Haen

    JAMA
    |November 17, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Newly synthesized drugs in the US increased from 25 (2001-2002) to 37 (2003-2004), showing therapeutic advancements. A few key drugs dominated prescriptions, aligning with their market presence.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Information--the key to the future.

    Drug information journal·1979
    Same author

    Parenteral drugs--commerce and science.

    Journal of the Parenteral Drug Association·1978
    Same author

    Drugs released for clinical use.

    Journal of clinical pharmacology·1978
    Same author

    Drug information for the patient--a different approach.

    Drug information journal·1977
    Same author

    Effect of legislation on the introduction of drugs. Is there a drug lag?

    Drug intelligence & clinical pharmacy·1976
    Same author

    The drug lag--does it exist in Europe?

    Drug intelligence & clinical pharmacy·1975
    Same journal

    WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

    JAMA·2026
    Same journal

    FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

    JAMA·2026
    Same journal

    HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

    JAMA·2026
    Same journal

    US Dietary Supplement Use Increasing, Especially in Older Adults.

    JAMA·2026
    Same journal

    Heat Stress From Climate Change Surges Globally.

    JAMA·2026
    Same journal

    Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

    JAMA·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Drug Development
    • Therapeutics

    Background:

    • The introduction of new drugs is a key indicator of pharmaceutical innovation.
    • Understanding drug market dynamics is crucial for healthcare providers and policymakers.

    Purpose of the Study:

    • To review the number and therapeutic classifications of newly synthesized drugs introduced in the US during 1973-1974.
    • To analyze prescription patterns and the market share of specific drug products.

    Main Methods:

    • Retrospective review of newly synthesized drug introductions in the US.
    • Analysis of prescription data, categorizing drugs by active ingredients and therapeutic class.

    Main Results:

    • Drug introductions rose to 37 in 1973-1974, an increase from 25 in 1971-1972.

    Related Experiment Videos

  • Newly synthesized drugs were categorized into nine major therapeutic classifications.
  • In 1974, 68% of prescriptions were filled with 200 drugs, with 126 single-ingredient and 76 multi-ingredient products.
  • Prescription volume correlated with the number of drug products within each therapeutic class.

    • Conclusions:

    • The period 1973-1974 showed an encouraging increase in new drug introductions.
    • New drugs offer significant therapeutic advances and options for physicians.
    • A concentrated number of drugs dominate the prescription market, reflecting their therapeutic importance and accessibility.